{"entity":{"id":"idea-acc-global-cancer-financing-window","kind":"idea","name":"A dedicated global financing window for cancer, modelled on the Global Fund","aka":[],"tldr":"Cancer kills more people in poorer countries than HIV, TB and malaria combined, but has no global fund. A pooled fund for diagnosis, essential medicines and radiotherapy would change what ministries can afford to build.","summary":"Development assistance for health has largely bypassed cancer. Despite rising burden in LMICs, there is no multilateral financing instrument for cancer services comparable to the Global Fund or Gavi. A financing window, whether a new fund or a cancer envelope inside an existing one, would co-finance national cancer control plans with conditions on registries, essential medicine availability, and palliative care. The design questions are governance, co-financing ratios, and how to avoid crowding out domestic spending.","asOf":"2026-09-08","links":[{"label":"Bottleneck evidence (Most of the world has almost no cancer care): WHO fact sheet, Cancer","url":"https://www.who.int/news-room/fact-sheets/detail/cancer"}],"tags":[],"related":["globocan"],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["iarc"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":["b-global-access","b-funding-allocation"],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"hypothesis":"Countries receiving co-financing tied to a costed national cancer plan will increase the proportion of patients receiving any cancer treatment by at least 50% within six years, measured through population-based registries.","rationale":"The Global Fund and Gavi showed that predictable, results-linked external finance plus technical assistance builds durable programmes; cancer control has the same structure of high fixed costs and long payback.","test":"A five-country pilot envelope with published disbursements, registry-based outcome tracking, and an independent evaluation against matched non-recipient countries.","maturity":"speculative","actor":"policy","cost":"large","horizonYears":6},"route":"/ideas/idea-acc-global-cancer-financing-window/","neighbours":{"collection":[{"id":"globocan","kind":"collection","name":"GLOBOCAN / Global Cancer Observatory","route":"/collections/globocan/"}],"institution":[{"id":"iarc","kind":"institution","name":"International Agency for Research on Cancer (IARC / WHO)","route":"/institutions/iarc/"}],"bottleneck":[{"id":"b-funding-allocation","kind":"bottleneck","name":"Funding follows fashion, not burden","route":"/bottlenecks/b-funding-allocation/"},{"id":"b-global-access","kind":"bottleneck","name":"Most of the world has almost no cancer care","route":"/bottlenecks/b-global-access/"}]}}